|
Market Cap (18-May) $7,515,405 (818th) |
Close (30-Jun) $0.004 |
Volume (30-Jun) 780,000 |
Shortsold (11-Feb) 8,518 (0.01%) (552nd) |
|
52w High $0.60 |
52w Low $0.095 |
P/E - |
EPS -0.11 |
IVX released this announcement to the ASX on 29 October 2021, 13:20. The announcement is not marked as price sensitive, and is 1 page(s) in length and 120.75kb in size.
You can view all announcements from IVX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IVX was 0.045% short sold according to ASIC data. It was ranked the 508th most shorted stock on the ASX. It remains ranked 552nd as of the latest reported data (11 February 2025).
| Other Recent Announcements from IVX | |
|---|---|
| Notification regarding unquoted securities - IVX | 11 May 2023, 8:38 |
| Change of Director's Interest Notice- Robert Merriel | 2 May 2023, 16:45 |
| Section 708A Cleansing Statement | 2 May 2023, 16:42 |
| Appointment of Company Secretary | 29 October 2021, 13:20 |
| Further Information on Proof of Concept Pilot Study | 29 October 2021, 8:52 |
| Complete Regression of TNBC Tumours and Protective Immunity | 28 October 2021, 9:43 |
| Activities Report and Appendix 4C | 21 October 2021, 14:53 |
You must be logged in to post a reply.
Invion 